We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
- Authors
Harousseau, J L; Witz, B; Lioure, B; Hunault-Berger, M; Desablens, B; Delain, M; Guilhot, F; Le Prise, P Y; Abgrall, J F; Deconinck, E; Guyotat, D; Vilque, J P; Casassus, P; Tournilhac, O; Audhuy, B; Solary, E
- Abstract
Ten years after the first clinical studies, the clinical impact of myeloid growth factors in acute myeloid leukemia is still unclear. One of the objectives of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques (GOELAM) 2 trial was to evaluate the benefit of granulocyte colony-stimulating factor (GCSF) given only after the two courses of intensive consolidation chemotherapy (ICC) used to maintain complete remission (CR).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Vol 18, Issue 4, p780
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2000.18.4.780